| Pedro A Castaing Lespier, MD | |
|
Urb. Industrial Reparada 2, 396 Dr. Luis F. Sala, Ponce, PR 00716 | |
| (787) 840-2575 | |
| Not Available |
| Full Name | Pedro A Castaing Lespier |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 24 Years |
| Location | Urb. Industrial Reparada 2, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184746224 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 13614 (Puerto Rico) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 13614 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tiber Health Public Benefit Corporation | 8820302979 | 11 |
News Archive
MindChild Medical, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.
Biothera announced today top-line results from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) that evaluated its immunotherapeutic drug candidate, Imprime PGG®, with cetuximab (Erbitux®), carboplatin and paclitaxel compared with the monoclonal antibody and chemotherapy combination alone.
Technion-Israel Institute of Technology researchers have discovered new mechanisms developed by cancer cells to become resistant to various chemotherapy drugs.
On Monday "in Brussels, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an appeal to government and private sector donors for $15 billion for the next three years," Joyce Banda, president of the Republic of Malawi, writes in the Huffington Post's "The Big Push" blog.
› Verified 7 days ago
| Entity Name | Tiber Health Public Benefit Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184139602 PECOS PAC ID: 8820302979 Enrollment ID: O20150803000978 |
News Archive
MindChild Medical, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.
Biothera announced today top-line results from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) that evaluated its immunotherapeutic drug candidate, Imprime PGG®, with cetuximab (Erbitux®), carboplatin and paclitaxel compared with the monoclonal antibody and chemotherapy combination alone.
Technion-Israel Institute of Technology researchers have discovered new mechanisms developed by cancer cells to become resistant to various chemotherapy drugs.
On Monday "in Brussels, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an appeal to government and private sector donors for $15 billion for the next three years," Joyce Banda, president of the Republic of Malawi, writes in the Huffington Post's "The Big Push" blog.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pedro A Castaing Lespier, MD Po Box 7004, Ponce, PR 00732-7004 Ph: (787) 840-2575 | Pedro A Castaing Lespier, MD Urb. Industrial Reparada 2, 396 Dr. Luis F. Sala, Ponce, PR 00716 Ph: (787) 840-2575 |
News Archive
MindChild Medical, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.
Biothera announced today top-line results from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) that evaluated its immunotherapeutic drug candidate, Imprime PGG®, with cetuximab (Erbitux®), carboplatin and paclitaxel compared with the monoclonal antibody and chemotherapy combination alone.
Technion-Israel Institute of Technology researchers have discovered new mechanisms developed by cancer cells to become resistant to various chemotherapy drugs.
On Monday "in Brussels, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an appeal to government and private sector donors for $15 billion for the next three years," Joyce Banda, president of the Republic of Malawi, writes in the Huffington Post's "The Big Push" blog.
› Verified 7 days ago
Dr. Dharma D. Suris, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 471 Calle Ferrocarril, Santa Maria Office Building, Ponce, PR 00717 Phone: 787-961-4841 | |
Nina M. Vega, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 472 Ave Tito Castro, Ste 401, Ponce, PR 00716 Phone: 787-848-7646 Fax: 787-290-7722 | |
Dr. Virgen Milagros Quinones Fernandini, MD, PSYCHIATRIST Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 701 Portales Del Monte, Ponce, PR 00780 Phone: 914-318-2258 Fax: 787-652-4773 | |
Dr. German Leroy Serrano Cruet, M.D, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2905 Local B, Calle Fagot, Ponce, PR 00716 Phone: 787-405-5818 | |
Dr. Hector L Rodriguez Sr., M.D. PSYCHIATRIST Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 8169 Calle Concordia, Ste 403, Ponce, PR 00717 Phone: 787-842-8152 Fax: 787-842-8152 | |
Reinaldo Jose Carreras, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 8169 Calle Concordia, Cond. San Vicente, Ste 210, Ponce, PR 00717 Phone: 787-842-5252 Fax: 787-848-5287 | |
Josue Caban Alvarez, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 388 Zona Ind Reparada 2, Ponce, PR 00716 Phone: 939-397-1766 |